Table 2.
Laboratory findings of patients infected with 2019-nCoV.
| All patients |
Mild group |
Severe group |
P-value |
|||||
|---|---|---|---|---|---|---|---|---|
| Level | N | n, % | N | n, % | N | n, % | ||
| lymphocytes | Decreased | 93 | 40 (43%) | 60 | 19(32%) | 33 | 21(64%) | 0.0029 |
| CD3+T | Decreased | 73 | 40(55%) | 48 | 22(46%) | 25 | 18(72%) | 0.0957 |
| CD4+T | Decreased | 73 | 39(53%) | 48 | 21(44%) | 25 | 18(72%) | 0.0676 |
| CD8+T | Decreased | 73 | 34(47%) | 48 | 17(35%) | 25 | 17(68%) | 0.0263 |
| B Cell | Decreased | 73 | 15(21%) | 48 | 12(25%) | 25 | 3(12%) | 0.1711 |
| NK Cell | Decreased | 73 | 23(32%) | 48 | 13(27%) | 25 | 10(40%) | 0.3557 |
| IL-2 | Normal | 93 | 93 (100%) | 60 | 60(100%) | 33 | 33 (100%) | NA |
| IL-4 | Normal | 93 | 93 (100%) | 60 | 60(100%) | 33 | 33 (100%) | NA |
| IL-6 | Increased | 93 | 72 (77%) | 60 | 42 (70%) | 33 | 30 (91%) | 0.0210 |
| IL-10 | Increased | 93 | 29(31%) | 60 | 13(22%) | 33 | 16(48%) | 0.0076 |
| TNF-α | Normal | 93 | 93 (100%) | 60 | 60 (100%) | 33 | 33 (100%) | NA |
| IFN-γ | Normal | 93 | 93 (100%) | 60 | 60 (100%) | 33 | 33 (100%) | NA |